5 Results for "

scopolamine-induced cognitive impairment

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "scopolamine-induced cognitive impairment" in MCE Product Catalog:

Cat. No.: HY-N4268
CAS No.: 139726-36-6
Tenuifoliside B, a component isolated from Polygalae Radix, inhibits potassium cyanide (KCN)-induced hypoxia and scopolamine-induced memory impairment. Tenuifoliside B shows potential cognitive improvement and cerebral protective effects. Tenuifoliside B has potential to become an anti-AD lead compound .
loading...
    loading...
Cat. No.: HY-163646
CAS No.: 2218754-19-7
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

(Rac)-TZ3O is the (Rac) isomer of TZ3O. TZ3O is an anticholinergic compound with neuroprotective activity. TZ3O improves memory impairment and cognitive decline in a scopolamine-induced Alzheimer's disease rat model and can be used in the study of Alzheimer's disease.
loading...
    loading...
Cat. No.: HY-146347
CAS No.: 2376710-36-8
Research Areas:  

Neurological Disease

MAO-B-IN-10 (compound 4f) is a potent, selective, BBB-penetrated MAO-B (monoamine oxidase-B) inhibitor, with IC50 of 5.3 μM. MAO-B-IN-10 can inhibit (58.2%) and disaggregate (43.3%) self-mediated Aβ (amyloid β) aggregation. MAO-B-IN-10 can be use for Alzheimer’s disease research .
loading...
    loading...
Cat. No.: HY-N20637
CAS No.: 176182-04-0
Polygalasaponin XXXII is an orally active cognitive enhancer. Polygalasaponin XXXII promotes the phosphorylation of ERK, CREB, Synapsin I and TrkB. Polygalasaponin XXXII enhances basal synaptic transmission. Polygalasaponin XXXII attenuates Scopolamine (HY-N0296)-induced cognitive impairment and improves hippocampus-dependent learning and memory abilities. Polygalasaponin XXXII can be used in research related to cognitive dysfunction .
loading...
    loading...
Cat. No.: HY-182581
CAS No.: 862310-66-5
Target:  

Histamine Receptor

Research Areas:  

Neurological Disease

MK-3134 is an orally active, brain-penetrant and selective histamine H3 receptor inverse agonist. MK-3134 modulates histaminergic neurotransmission, decreases constitutive H3 receptor signaling, releases tonic inhibition of neurotransmitter release, potentiates neurotransmission, and may enhance cholinergic neurotransmission. MK-3134 can be used for the research of Alzheimer's disease .
loading...
    loading...